Eyeworld

MAR 2020

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1215009

Contents of this Issue

Navigation

Page 17 of 118

MARCH 2020 | EYEWORLD | 15 Contact Kliman: gkliman@interwest.com practice and enhancing their abilities to play a role as innovation evangelists in both corporate and patient care settings. Describe the role physicians have played in helping you build the agenda and meeting culture. Dr. Kliman: The program development has been led by the co-chairs of our first meeting, Eric Donnenfeld, MD, Edward Holland, MD, Thomas Samuelson, MD, and Elizabeth Yeu, MD, who are all ASCRS leaders and practicing ophthalmologists. Their tremendous talents in both clinical practice and ophthalmic business innovation have allowed us to create a superbly powerful and differentiated innovation meeting agenda. It will be broken up into a mix of panel discussions, company presentations, breakout sessions, and novel interactive formats. In addition to the program content, the co-chairs focused on creating opportunities for people to network, talk, learn, and brainstorm, and it's a way for people from both business and clinical settings to connect. Our meeting culture is centered on diversity and everyone being on a level playing field, with everyone learning from each other through respectful and objective interactions. What are the top three or four highlights from the day you have planned? Dr. Kliman: One of the unique things that we're doing is bringing in keynote speaker Gary Pisano, a Harvard Business School professor, who will be leading an interactive session on innovation for both large and small companies. We have also created an entirely new exhibitor concept called the Eyecelerator Marketplace, where even the smallest companies can have an interactive kiosk providing a digital presence and facilitating attendee interactions throughout the whole meeting. We have a special session on real-world data highlighting the achievements of the IRIS Registry (AAO). We have made a big effort to bring in fresh content with new companies both large and small and dynamic speakers that have never before presented at a conference like this one. What does it mean to have the two largest societies in ophthalmology partner on this venture? Dr. Kliman: It's a powerful new partnership that hasn't been seen before in any medical field, with two societies coming together to form a joint meeting in innovation. For me, as a ven- ture capitalist, investing across all areas of medi- cine, I see it as unprecedented and unique, and I think it will speed innovation for the industry, and it will let investors like myself see a broader spectrum of companies. We're trying to make entry for companies coming to the meeting as easy and cost-effective as possible so we can have many more companies. It's going to be a smorgasbord of all types of technologies, and the diversity and collegial discourse should have a positive impact on innovation that only a soci- ety-partnered meeting can deliver. Eyecelerator program highlights •Developing New Category Marketplaces •Innovation Keynote Talk and Interactive Discussion with Professor Gary Pisano •Real-World Data: IRIS + MIGS •Wall Street View of Ophthalmology Markets Register now at Eyecelerator.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - MAR 2020